Citations 2
Achieving a Representative Sample of Asian Americans in Biomedical Research Through Community-Based Approaches: Comparing Demographic Data in the All of Us Research Program With the American Community Survey
Randal, Fornessa T., Lozano, Paula , Qi, Siya, Maene, Chieko, Shah, Sameep , Mo, Yicklun, Ratsimbazafy, Francis, Boerwinkle, Eric , Cicek, Mine , Loperena, Roxana , Mayo, Kelsey , Mockrin, Stephen, Ohno‐Machado, Lucila , Schully, Sheri D. , Ramirez, Andrea H. , Aschebrook‐Kilfoy, Briseis , Ahsan, Habibul , Lam, Helen , Kim, Karen E., Clark, Cheryl R. , Cohn, Elizabeth, Gebo, Kelly A , Kim, Karen E.
Journal of Transcultural Nursing | November 18, 2022 | Volume: 34 | Issue: 1 | Pages: 59-67
Background: Underrepresented persons are often not included in biomedical research. It is unknown if the general Asian American population is being represented in All of Us . The purpose of this study was to compare the Asian demographic data in the All of Us cohort with the Asian nationally representative data from the American Community Survey. Method: Demographic characteristics and health literacy of Asians in All of Us were examined. Findings were qualitatively compared with the Asian data in the 2019 American Community Survey 1-year estimate. Results: Compared with the national composition of Asians, less All of Us participants were born outside the United States (64% vs 79%), were younger, and had higher levels of education (76% vs 52%). Over 60% of All of Us participants reported high levels of health literacy. Conclusion: This study had implications for the development of strategies that ensure diverse populations are represented in biomedical research.
Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence
Schlueter, David J., Garbett, Shawn , Ratsimbazafy, Francis, Karlson, Elizabeth W. , Cicek, Mine , Malin, Bradley , Ohno‐Machado, Lucila , Williams, Carolyn , Goldstein, David B. , Kouame, Aymone, Ramirez, Andrea H. , Schully, Sheri D. , Miller, Cheryl N , Pinto, Ligia A , Althoff, Keri N. , Anton‐Culver, Hoda , Chen, Qingxia , Thomsen, Isaac P. , Gebo, Kelly A
mSphere | September 29, 2022 | Volume: 7 | Issue: 5 | Pages: No page available
What is the agreement of commercial SARS-CoV-2 immunoglobulin G (IgG) assays during a time of low coronavirus disease 2019 (COVID-19) prevalence and no vaccine availability? Serological tests produced concordant results in a time of low SARS-CoV-2 prevalence and no vaccine availability, driven largely by the proportion of samples that were negative by two immunoassays. The CDC recommends two sequential tests for positivity for future pandemic preparedness.